VISIONGATE INC

Profile

Company Names

VISIONGATE INC

Addresses

10220 S. 51ST STREET, SUITE 2, PHOENIX, AZ 85044

275 N. GATEWAY DR., PHOENIX, AZ 85034

445 N. 5TH STREET, 3RD FLOOR, PHOENIX, AZ 85004

1509 56TH AVE COURT N W, GIG HARBOR, WA 98335

Phone Numbers

602-368-2118
253-265-0033

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

WA

Total Amount Raised:

$52,276,960.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-06-06 
$3,748,247.00 
$10,000,000.00 
$6,251,753.00 
Equity 
5
2014-09-30 
$5,332,200.00 
$5,500,000.00 
$167,800.00 
Debt 
4
2013-06-06 
$36,563,440.00 
$43,000,001.00 
$6,436,561.00 
Equity 
3
2010-09-06 
$4,363,073.00 
$8,000,000.00 
$3,636,927.00 
Equity 
2
2008-11-06 
$490,000.00 
$1,200,000.00 
$710,000.00 
Debt 
1
2008-01-20 
$1,780,000.00 
$3,500,000.00 
$1,720,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
C. 
BATEMAN 
EXECUTIVE OFFICER
RANDY 
 
BUNESS 
EXECUTIVE OFFICER
RANDY 
L. 
BUNESS 
EXECUTIVE OFFICER
MICHAEL 
 
DOHERTY 
DIRECTOR
SHARON 
K. 
EVERSON 
DIRECTOR
MARIA 
 
FORERO 
DIRECTOR
JOHN 
 
GLASSPOOL 
EXECUTIVE OFFICER, DIRECTOR
JOE 
 
HEALEY 
DIRECTOR
ROBERT 
A. 
HEFT 
DIRECTOR
THOMAS 
C. 
MILLER 
DIRECTOR
ALAN 
C. 
NELSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GENE 
F. 
PAWLICK 
DIRECTOR
WALTER 
L. 
ROBB 
DIRECTOR
SCARLETT 
 
SPRING 
EXECUTIVE OFFICER, PROMOTER
TANISHA JUNE-NICHOLE 
 
VILLANUEVA 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-06 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2008-11-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#